COMMENTARY |
Department of Pediatrics, University of Colorado, Denver, Colorado
In 1982, with major funding from the Robert Wood Johnson Foundation, a team of investigators initiated an 8-site randomized, controlled trial of an educational intervention for preterm and low birth weight newborns known as the Infant Health and Development Program. Although interventions had been tested for this population in earlier studies,1 this trial was unique in its boldness of program and research design.
The investigators adapted a promising program for the intervention that consisted of home visiting and educationally enriched day care for children who were aged 0 to 3 years, which previously had been tested with young children and their families living in poverty.2 Fortunately, the investigators stratified the randomization by birth weight (
2000 vs 20012500 g). In earlier phases of follow-up, the investigators found large intervention effects on cognition and behavior at the end of the program, with those benefits concentrated in children who were born in the higher birth weight stratum.3 By age 5 and 8, those effects began to attenuate, especially for those in the lower birth weight subsample.4,5
In this month's issue of Pediatrics, McCormick et al6 report the results of a follow-up of the children at age 18. Among children in the higher low-birth weight group, those in the intervention group had better language development and math achievement and fewer risky behaviors compared with control-group counterparts. There were no discernible long-term benefits for children in the lower low-birth weight stratum. Also, there were no effects for either birth weight group on grade retention and placement in special education, which are outcomes that might help offset the high cost of the intervention. Although effects for the higher-weight children are modest, it is remarkable that, 18 years after birth, the program signal could be detected at all.
Knowing now that it is possible to alter the long-term trajectories of newborns in the 2000- to 2500-g range, we are in a position to ask new questions:
This current trial is of immense significance in telling us that something important can be achieved for vulnerable infants born in the 2000- to 2500-g range. Now we need to find ways of helping those with lower weights and doing so at lower cost.
| FOOTNOTES |
|---|
Address correspondence to David Olds, PhD, Department of Pediatrics, 1825 Marion St, Denver, CO 80218. E-mail: olds.david{at}tchden.org
The author has indicated he has no financial relationships relevant to this article to disclose.
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||